OAM
RXST icon

Oberweis Asset Management’s RxSight RXST Stock Holding History

Oberweis Asset Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,040
Closed -$655K – 208
2024
Q4 		$655K Sell
19,040
-107,600
-85% -$4.85M 0.03% 181
2024
Q3 		$6.26M Hold
126,640
– – 0.32% 119
2024
Q2 		$7.62M Hold
126,640
– – 0.47% 79
2024
Q1 		$6.53M Buy
126,640
+43,540
+52% +$2.14M 0.47% 83
2023
Q4 		$3.35M Buy
+83,100
New +$2.44M 0.31% 127

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Oberweis Asset Management's RXST Position: Q1 2025 in Review

Oberweis Asset Management sold out of RxSight (RXST) in Q1 2025, closing a stake of 19,040 shares — an estimated $655K sold.

Oberweis Asset Management first reported a position in RXST in Q4 2023 and held it in 5 quarters. The position peaked at $7.62M in Q2 2024. 192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

  • Oberweis Asset Management reported no remaining RxSight position as of Q1 2025 after selling out during the quarter.
  • Oberweis Asset Management sold 19,040 RxSight shares in Q1 2025, an estimated $655K.
  • Oberweis Asset Management first reported a position in RxSight in Q4 2023 and held it in 5 quarters.
  • Oberweis Asset Management's RxSight position peaked at $7.62M in Q2 2024.
  • 192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on Oberweis Asset Management's 13F filing for Q1 2025, filed 15 May 2025.